Madrigal Pharmaceuticals (MDGL) Q4 2025 Earnings

Nov 4Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-5.08
-4.02
-2.96
-1.9

Details

Expected EPS
-2.285109
Actual EPS
-5.08
Surprise EPS
-2.79
Surprise Percent
-122.31%

Description

⁨Madrigal Pharmaceuticals⁩ (⁦MDGL⁩) has reported earnings of ⁦-5.08⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts